High-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection Letter uri icon

Overview

MeSH Major

  • Graft Rejection
  • Immunoglobulins, Intravenous
  • Pancreas Transplantation

publication date

  • September 11, 2013

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1097/TP.0b013e3182a04974

PubMed ID

  • 23995870

Additional Document Info

start page

  • e43

end page

  • 4

volume

  • 96

number

  • 5